15 results on '"Iancovici-Kidon M"'
Search Results
2. Immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency
- Author
-
Shavit, R, primary, Maoz-Segal, R, additional, Prizinsky, S, additional, Haj-Yahia, S, additional, Offengenden, I, additional, Machnas-Mayan, D, additional, Tunisky, Y, additional, Iancovici-Kidon, M, additional, and Agmon-Levin, N, additional
- Published
- 2021
- Full Text
- View/download PDF
3. Is it ‘bad hygiene’ to inhale pollen in early life?
- Author
-
Geller-Bernstein, C., Lahoz, C., Cárdaba, B., Hassoun, G., Iancovici-Kidon, M., Kenett, R., and Waisel, Y.
- Published
- 2002
4. Does skin prick test correlate with basophil-associated mite-specific IgE in atopic children?
- Author
-
Iancovici Kidon, M., Geller-Bernstein, C., Dwir, G., Licht, A., Ron Kenett, and Pecht, I.
- Subjects
Hypersensitivity, Immediate ,Male ,Adolescent ,Pyroglyphidae ,Immunoglobulin E ,Basophils ,Hypersensitivity ,Humans ,Female ,Antigens, Dermatophagoides ,Mast Cells ,Child ,Rhinitis ,Skin Tests - Abstract
Skin prick test (SPT), as the standard diagnostic tool for immediate hypersensitivity to aeroallergens, is an expression of IgE-dependent mediator release from dermal mast cells. Though probably involved in the late-phase response, peripheral blood basophils (PBB) don't seem to participate in the immediate hypersensitivity response in the skin. We aimed to assess a possible correlation between the SPT to mites and levels of basophil-associated mite-specific IgE. We sequentially enrolled 15 children with allergic rhinitis and documented classII mite sensitization, mean age 13 years (range 9.5-18), 11 males, 4 females. Symptoms score was determined using a validated questioner. SPT area under the curve (AUC) for 10 common respiratory allergens was measured in all patients. Heparinized blood after basophil enrichment, was lysed with CHAPS. Determination of allergen-specific and total IgE in serum and cell lysate supernatant was performed using standard commercial kits. Basophil-associated, mite-specific IgE could be reliably determined only in 10 patients with a skin reaction greater than 70 mm2, OR 36 (95% CI 1.8-732, p = 0.02). We found a strong linear correlation (R2 = 0.74, p = 0.001) between mite-specific basophil-associated IgE density (IgE molecules per cell) and the SPT AUC. This finding suggests that skin mast cell precursors and basophil both bind specific IgE at a common site prior to the arrival of mast cells to the skin.
5. Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines.
- Author
-
Shavit R, Maoz-Segal R, Offengenden I, Yahia SH, Maayan DM, Lifshitz Y, Niznik S, Deutch M, Elbaz E, Genaim H, Iancovici-Kidon M, and Agmon-Levin N
- Subjects
- BNT162 Vaccine, ChAdOx1 nCoV-19, Cough, Epinephrine, Excipients, Humans, Immunization, COVID-19 prevention & control, COVID-19 Vaccines adverse effects, Hypersensitivity diagnosis, Hypersensitivity, Immediate diagnosis, Vaccines adverse effects
- Abstract
Background: Allergic reactions to the coronavirus disease 2019 (COVID-19) vaccines have raised concerns, particularly as repeated doses are required. Skin tests with the vaccines excipient were found to be of low value, whereas the utility of skin tests with the whole vaccine is yet to be determined., Objective: To evaluate a panel of skin tests and the outcomes of subsequent doses of immunization among subjects who suffered an immediate allergic reaction to the BioNTech (BNT162b2) COVID-19 vaccine., Methods: Between March and December 2021, patients who experienced symptoms consistent with immediate allergic reactions to the BNT162b2 vaccine and were referred to the Sheba Medical Center underwent skin testing with polyethylene glyol (PEG)-containing medicines, Pfizer-BNT162b2, and Oxford-AstraZeneca vaccine (AZD1222). Further immunization was performed accordingly and under medical observation., Results: A total of 51 patients underwent skin testing for suspected allergy to the COVID vaccines, of which 38 of 51 (74.5%) were nonreactive, 7 of 51(13.7%) had no skin sensitization but suffered a clinical reaction during skin testing (mainly cough), and 6 of 51 (11.7%) exhibited immediate skin sensitization. Both skin sensitization and cough during testing were related to a higher use of adrenaline following immunization (P = .08 and P = .024, respectively). Further immunization with the BNT162b2 vaccine was recommended unless sensitization or severe reaction to previous immunization was evident. The latter were referred to be tested/receive the alternative AZD1222 vaccine. Ten patients underwent skin testing with AZD1222: 2 of 10 (20%) demonstrated skin sensitization to both vaccines; thus, 8 of 10 were immunized with the AZD1222, of which 2 of 8 (25%) had allergic reactions., Conclusions: Immediate allergic reactions to COVID-19 vaccines are rare but can be severe and reoccur. Intradermal testing with the whole vaccine may discriminate sensitized subjects, detect cross-sensitization between vaccines, and enable estimation of patients at higher risk., (Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
6. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
- Author
-
Shavit R, Maoz-Segal R, Iancovici-Kidon M, Offengenden I, Haj Yahia S, Machnes Maayan D, Lifshitz-Tunitsky Y, Niznik S, Frizinsky S, Deutch M, Elbaz E, Genaim H, Rahav G, Levy I, Belkin A, Regev-Yochay G, Afek A, and Agmon-Levin N
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anaphylaxis epidemiology, BNT162 Vaccine, Female, Humans, Hypersensitivity epidemiology, Hypersensitivity etiology, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, SARS-CoV-2, Young Adult, Anaphylaxis etiology, COVID-19 prevention & control, COVID-19 Vaccines adverse effects, Vaccination adverse effects
- Abstract
Importance: Allergic reactions among some individuals who received the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine discourage patients with allergic conditions from receiving this vaccine and physicians from recommending the vaccine., Objective: To describe the assessment and immunization of highly allergic individuals with the BNT162b2 vaccine., Design, Setting, and Participants: In a prospective cohort study from December 27, 2020, to February 22, 2021, 8102 patients with allergies who applied to the COVID 19 vaccine referral center at the Sheba Medical Center underwent risk assessment using an algorithm that included a detailed questionnaire. High-risk patients (n = 429) were considered "highly allergic" and were immunized under medical supervision., Exposures: Pfizer-BioNTech (BNT162b2) COVID-19 vaccine., Main Outcomes and Measures: Allergic and anaphylactic reactions after the first and second doses of BNT162b2 vaccine among highly allergic patients., Results: Of the 429 individuals who applied to the COVID-19 referral center and were defined as highly allergic, 304 (70.9%) were women and the mean (SD) age was 52 (16) years. This highly allergic group was referred to receive immunization under medical supervision. After the first dose of the BNT162b2 vaccine, 420 patients (97.9%) had no immediate allergic event, 6 (1.4%) developed minor allergic responses, and 3 (0.7%) had anaphylactic reactions. During the study period, 218 highly allergic patients (50.8%) received the second BNT162b2 vaccine dose, of which 214 (98.2%) had no allergic reactions and 4 patients (1.8%) had minor allergic reactions. Other immediate and late reactions were comparable with those seen in the general population, except for delayed itch and skin eruption, which were more common among allergic patients., Conclusions and Relevance: The rate of allergic reactions to BNT162b2 vaccine, is higher among patients with allergies, particularly among a subgroup with a history of high-risk allergies. This study suggests that most patients with a history of allergic diseases and, particularly, highly allergic patients can be safely immunized by using an algorithm that can be implemented in different medical facilities and includes a referral center, a risk assessment questionnaire, and a setting for immunization under medical supervision of highly allergic patients. Further studies are required to define more specific risk factors for allergic reactions to the BNT162b2 vaccine.
- Published
- 2021
- Full Text
- View/download PDF
7. Combined immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency
- Author
-
Shavit R, Maoz-Segal R, Frizinsky S, Haj-Yahia S, Offengenden I, Machnas-Mayan D, Tunisky Y, Iancovici-Kidon M, and Agmon-Levin N
- Subjects
- Adult, Autoimmunity immunology, Female, Humans, Male, Middle Aged, Phenotype, Retrospective Studies, Common Variable Immunodeficiency immunology, Lymphopenia immunology, Neoplasms immunology, Primary Immunodeficiency Diseases immunology
- Abstract
Primary immunodeficiency disorders (PID) are a group of heterogeneous disorders characterized by recurrent infections, autoimmunity, increased lymphoproliferative disorders and other malignancies. PID is classified into cellular or humoral disorders or a combination of both. We evaluated the clinical differences among adult patients with three variants of PID: common variable immunodeficiency (CVID), idiopathic CD4 lymphopenia (ICL) and combined immunodeficiency (CID). We retrospectively compared demographics, immunological characteristics, clinical presentations and outcomes of CVID, CID and ICL patients followed from 2012 to 2018. In our cohort, we identified 44 adult patients diagnosed with CVID (22), CID (11) and ICL (11). Malignancy was associated with CID, as seven of 11 patients in this group were diagnosed with malignancy compared to CVID (three of 22) or ICL (two of 11) (P = 0·002 and 0·03, respectively). Malignancies were also linked to male gender [odds ratio (OR) = 5, 95% confidence interval (CI) = 1·12-22·18) P = 0·0342] and a low ratio of CD4/CD8 < 0·8 (OR = 5·1, 95% CI = 1·22-21·28, P = 0·025). Among CID and ICL, two of 11 patients died in each group, while no death was documented among CVID group (P = 0·04). Autoimmune manifestations did not differ between groups. Similarly, the rate of infections was similar between groups, although infectious agents vary. CID is associated with a high risk of malignancy compare to CVID or ICL. Among adults with PID, male gender, low CD4 and a CD4/CD8 ratio of < 0·8 may serve as risk factors of concomitant malignancy. Surveillance of lymphocyte subpopulations should be considered for all adults., (© 2021 British Society for Immunology.)
- Published
- 2021
- Full Text
- View/download PDF
8. Pilot study of the use of Yin Qiao San in children with conventional antipyretic hypersensitivity.
- Author
-
Liew WK, Loh W, Chiang WC, Goh A, Chay OM, and Iancovici Kidon M
- Abstract
Background: Children with a diagnosis of cross-reactive hypersensitivity to both paracetamol and nonsteroidal anti-inflammatory drugs are limited in their choice of antipyretics., Objective: The aim of this pilot study is to evaluate the feasibility of using a Chinese proprietary medicine, Yin Qiao San (YQS), for fever relief., Methods: A single centre, open label, prospective clinical trial exploring the tolerability and feasibility of using YQS for fever relief in children who are unable to use conventional antipyretic medications. Children between 1-18 years of age with hypersensitivity to multiple antipyretics were recruited. Eligible participants underwent an oral provocation test with YQS. Children who passed the oral provocation test were instructed to take a prescribed dose of YQS when the temperature was >38.0℃ and continued till the fever settled. Time taken for fever resolution and any adverse events were collected., Results: A total of 21 children, mean age 10.7 years, had a diagnosis of paracetamol and ibuprofen hypersensitivity. All except one patient successfully tolerated an oral challenge of YQS. Of the 88 doses of YQS taken for fever over 38.0℃, 16 (18%) had documented temperature reduction 2 hours after ingestion and 30 (34%) had documented temperature reduction 4 hours after ingestion. There were 2 reports of urticaria after YQS use which were attributed to flare of recurrent spontaneous urticaria during the illness. None of the patients developed symptoms of circulatory compromise or respiratory distress., Conclusion: YQS is generally well tolerated in patients with paracetamol and ibuprofen hypersensitivity.
- Published
- 2015
- Full Text
- View/download PDF
9. Allergy and clinical immunology. Preface.
- Author
-
Iancovici Kidon M
- Subjects
- Adolescent, Asthma epidemiology, Child, Preschool, Food Hypersensitivity epidemiology, Humans, Allergy and Immunology, Asthma immunology, Food Hypersensitivity immunology, Immune System physiology
- Published
- 2008
10. Increased Th1 and Th2 type cytokine production in patients with active tuberculosis.
- Author
-
Handzel ZT, Barak V, Altman Y, Bibi H, Lidgi M, Iancovici-Kidon M, Yassky D, and Raz M
- Subjects
- Case-Control Studies, Emigration and Immigration, Ethiopia ethnology, Europe, Eastern ethnology, Humans, Interferon-gamma, Interleukin-10, Interleukin-2, Interleukin-6, Israel, Severity of Illness Index, Tuberculosis ethnology, Cytokines metabolism, Mycobacterium tuberculosis pathogenicity, Th1 Cells pathology, Th2 Cells pathology, Tuberculosis immunology, Tuberculosis physiopathology
- Abstract
Background: The global spread of tuberculosis necessitates the development of an effective vaccine and new treatment modalities. That requires a better understanding of the differences in regulation of the immune responses to Mycobacterium tuberculosis between individuals who are susceptible or resistant to the infection. Previous immune studies in young Ethiopian immigrants to Israel did not demonstrate anergy to purified protein derivative or a Th2-like cytokine profile., Objectives: To evaluate the profile of Th1 and Th2 cytokine production in immigrant TB patients, in comparison with asymptomatic control subjects., Methods: The present study included (part 1): 39 patients with acute TB (group 1), 34 patients with chronic relapsing TB (group 2), 39 Mantoux-positive asymptomatic TB contacts (group 3), and 21 Mantoux-negative asymptomatic controls (group 4). Patients were mainly immigrants from Eastern Europe and Ethiopia. Levels of interferon gamma, interleukin 2 receptor, IL-6 and IL-10 were measured in serum and in non-stimulated and PPD-stimulated peripheral blood mononuclear cell culture supernatants, using commercial ELISA kits. In addition (part 2), levels of IFNgamma and IL-12p40 were evaluated in 31 immigrant Ethiopian patients and 58 contact family members., Results: Patients with acute disease tended to secrete more cytokines than contacts, and contacts more than chronic patients and controls, without a specific bias. None of the patients showed in vitro anergy. Discriminant probability analysis showed that from the total of 12 available parameters, a cluster of 6 (IFNgamma-SER, IFNgamma-PPD, IL-2R-SER, IL-10-SER, IL-10-NS and IL-6-PPD) predicted an 84% probability to become a TB contact upon exposure, 71% a chronic TB patient and 61% an acute TB patient. Family-specific patterns of IFNgamma were demonstrated in the second part of the study., Conclusions: Firstly, no deficiency in cytokine production was demonstrated in TB patients. Secondly, acute TB patients secreted more cytokines than contacts, and contacts more than unexposed controls. Thus, neither anergy nor a cytokine dysregulation explains susceptibility to acute TB disease in our cohort, although chronic TB patients produced less cytokines than did acute patients and less than asymptomatic contacts. Thirdly, a certain cytokine configuration may predict a trend of susceptibility to acquire, or not acquire, clinical TB. It is presently unclear whether this finding may explain the disease spread in large populations. Finally, the familial association of IFNgamma secretion levels probably points towards a genetic regulation of the immune response to Mycobacterium tuberculosis.
- Published
- 2007
11. Component-specific immunoglobulin E in the diagnosis of allergic disease in childhood: more of the same or something more?
- Author
-
Iancovici-Kidon M and Tim CF
- Subjects
- Age Factors, Animals, Child, Epitopes, Food Hypersensitivity, Fungi, Humans, Hypersensitivity immunology, Pollen, Pyroglyphidae, Hypersensitivity diagnosis, Immunization, Immunoglobulin E
- Published
- 2007
12. Serum immunoglobulin E levels in Israeli-Ethiopian children: environment and genetics.
- Author
-
Iancovici Kidon M, Stein M, Geller-Bernstein C, Weisman Z, Steinberg S, Greenberg Z, Handzel ZT, and Bentwich Z
- Subjects
- Adolescent, Asthma genetics, Environment, Eosinophilia blood, Eosinophilia genetics, Ethiopia ethnology, Female, Helminthiasis blood, Helminthiasis diagnosis, Humans, Immunoglobulin E genetics, Israel, Male, Time Factors, Asthma blood, Immunoglobulin E blood
- Abstract
Background: Since 1984, several waves of Ethiopian immigrants have settled in Israel. On arrival they were found to be highly infected with intestinal parasites and to have increased serum immunoglobulin E and eosinophilia., Objectives: To study serum IgE levels in Ethiopian children growing up in the environment of Israel., Methods: We assessed four groups of children of Ethiopian origin: a) adolescents examined on their arrival to Israel (group 1, n=11); b) adolescents born in Ethiopia and living in Israel for more than 7 years (group 2, n=10); c) children of Ethiopian origin born in Israel, without a history of allergy or asthma (group 3, n=15); and d) asthmatic children of Ethiopian origin born in Israel (group 4, n=8). A thorough clinical interview and examination as well as laboratory work up (including serum IgE levels, stool parasites and absolute eosinophil count) were performed., Results: Group 1 (11 newly arrived Ethiopian adolescents) had a mean eosinophil count of 688 cells/ml (0-1739) and a mean serum IgE of 1043 IU/ml (253-2932), P< 0.0009 as compared to group 2. Helminthic parasites were observed in 8/11 individuals; after 1 year of follow-up and anti-parasitic treatment, serum IgE levels did not change significantly. Group 2 (10 Ethiopian born adolescents living in Israel for on average 10 years, 7-15 years) had a normal leukocyte count, MEC 192 cells/ml (range 54-289), serum IgE 142 IU/ml (range 14-399 IU/ml) and no parasites in stool. Group 3 (15 Ethiopian children born in Israel) had a normal leukocyte count, MEC 128 cells/ml (0-324), serum IgE 55 IU/ml (7-189 IU/ml), similar to age-matched Israeli controls. In group 4 (8 Israeli born children of Ethiopian descent diagnosed with asthma), serum IgE showed significant elevation compared to Israeli age-matched asthmatic children (P< 0.005)., Conclusions: High levels of IgE found in Ethiopian children on arrival to Israel declined to Israeli control levels after several years of living in the new environment. Ethiopian children born in Israel had normal levels of IgE, suggesting that environment is the main factor affecting IgE levels in this population. Israeli born Ethiopian children with asthma had significantly increased serum IgE levels compared to asthmatics of Israeli origin. These findings suggest that both environmental and genetic factors determine the level of serum IgE in these children.
- Published
- 2005
13. Cross-reactive hypersensitivity to COX inhibitors in a child with mild allergic rhinitis.
- Author
-
Iancovici Kidon M, Abramovitch I, Steinberg S, and Barash J
- Subjects
- Angioedema chemically induced, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Child, Drug Hypersensitivity, Female, Humans, Acetaminophen adverse effects, Analgesics, Non-Narcotic adverse effects, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Cyclooxygenase Inhibitors adverse effects, Ibuprofen adverse effects, Rhinitis, Allergic, Perennial drug therapy, Urticaria chemically induced
- Published
- 2005
14. [Diagnosis of drug hypersensitivity--state of the art].
- Author
-
Iancovici-Kidon M and Handzel ZT
- Subjects
- Drug Hypersensitivity immunology, Drug Hypersensitivity physiopathology, Humans, Lymphocyte Activation, Drug Hypersensitivity diagnosis, Drug-Related Side Effects and Adverse Reactions
- Abstract
Adverse drug reactions are ubiquitous in outpatient as well as inpatient clinical care. An allergic drug reaction is an immunologically mediated adverse drug reaction that exhibits specificity and recurrence on re-exposure to the offending drug. The diagnosis and treatment of drug allergies is limited by a number of factors. In most instances the exact epitope causing the reaction is unknown, the immunological mechanism is unclear, the presence of immunological recognition is not predictive of a clinical reaction and the gold standard for diagnosis, the drug challenge, a complicated and sometimes dangerous endeavor. Nevertheless, during the past few years a serious attempt at standardization and validation of in vitro and in vivo techniques for the diagnosis of drug allergies, has been in progress. New methods, like the basophil surface marker for activation, CD63 are replacing old ones like histamine release for immediate type hypersensitivity reactions. For instance, in the field of beta-lactam hypersensitivity, the specific epitopes are better defined and standardized protocols for both immediate and delayed type reactions are in the process of being introduced. A standardized European Network of Drug Allergies (ENDA) questioner, published in 1999, permits systematic data gathering of events surrounding the acute drug reaction, facilitating later immunological investigation and diagnosis. This review attempts to summarize the present and some of the future options in the diagnosis of this common iatrogenic complication.
- Published
- 2002
15. A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD "Rehovot") in a Jewish Ethiopian family with variable phenotypes.
- Author
-
Iancovici-Kidon M, Sthoeger D, Abrahamov A, Wolach B, Beutler E, Gelbart T, and Barak Y
- Subjects
- Anemia, Hemolytic, Congenital Nonspherocytic complications, Anemia, Hemolytic, Congenital Nonspherocytic genetics, Child, Child, Preschool, Ethiopia, Exons, Family Health, Humans, Infant, Male, Neutropenia congenital, Neutropenia etiology, Neutropenia genetics, Phenotype, Glucosephosphate Dehydrogenase genetics, Jews genetics, Point Mutation
- Abstract
Hereditary nonspherocytic hemolytic anemia (HNSHA) is a rare manifestation of glucose-6-phosphate dehydrogenase (G6PD) gene mutations, caused mainly by mutations located in exon 10 of the G6PD gene and less commonly by mutations in other parts of the gene. A new, exon 9, single-base mutation representing a T --> C transition at cDNA nucleotide 964 was found in three brothers and their carrier mother of Jewish Ethiopian descent. Biochemical characterization of the resultant protein was not performed. Though clinical manifestations included HNSHA in all cases, the severity of hemolysis and the transfusion requirement differed markedly. Severe congenital neutropenia (Kostmann's syndrome)--a disorder never reported before in conjunction with G6PD deficiency--was observed in one case. Levels of white blood cell G6PD activity of the three patients were 0-5% of normal controls. Neutrophil oxidative and bactericidal activities were inherently impaired in the patient with Kostmann's syndrome, but were well preserved in his two siblings., (Copyright 2000 Academic Press.)
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.